Table 2.

Comparison of performance of disease activity, damage, and laboratory indices between academic and nonacademic rheumatologists.

IndexGroupSurvey Responses, n (%)p*
AlwaysSometimesNeverWould Like To
SLEDAI, n = 145Academic, n = 9624 (25)29 (30)31 (32)12 (13)0.002
Nonacademic, n = 492 (4)17 (35)26 (53)4 (8)
BILAG, n = 150Academic, n = 1011 (1)20 (20)70 (69)10 (10)0.02
Nonacademic, n = 490 (0)3 (6)42 (86)4 (8)
SLAM, n = 149Academic, n = 1013 (3)16 (16)78 (77)4 (4)0.03
Nonacademic, n = 480 (0)2 (6)42 (88)4 (8)
SLICC, n = 150Academic, n = 1012 (2)22 (22)67 (66)10 (10)0.02
Nonacademic, n = 490 (0)4 (8)41 (84)4 (8)
ANA, n = 146Academic, n = 10214 (14)27 (26)61 (60)0 (0)0.04
Nonacademic, n = 4412 (27)2 (5)15 (34)15 (34)
ENA, n = 152Academic, n = 10418 (17)23 (22)62 (60)1 (1)0.01
Nonacademic, n = 486 (13)31 (65)11 (23)0 (0)
dsDNA, n = 151Academic, n = 10271 (71)29 (28)2 (2)0 (0)1
Nonacademic, n = 4935 (71)12 (24)2 (4)0 (0)
  • * Cochran-Armitage trend test. SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; BILAG: British Isles Lupus Assessment Group index; SLAM: Systemic Lupus Activity Measure; SLICC: Systemic Lupus International Collaborating Clinics; ANA: antinuclear antibody; ENA: extractable nuclear antigen.